郝会民,李杨世玉,黄爱,等.儿童自身免疫性多内分泌腺病综合征 Ⅰ型 2例并文献复习[J].安徽医药,2024,28(9):1871-1875. |
儿童自身免疫性多内分泌腺病综合征 Ⅰ型 2例并文献复习 |
Autoimmune polyendocrinopathy syndrome type Ⅰ in children: two case reports and literature review |
|
DOI:10.3969/j.issn.1009-6469.2024.09.038 |
中文关键词: 多内分泌腺疾病,自身免疫性 AIRE基因 念珠菌病,慢性黏膜皮肤 甲状旁腺功能减退症 肾上腺皮质功能减退症 |
英文关键词: Polyendocrinopathies, autoimmune AIRE gene Candidiasis, chronic mucocutaneous Hypoparathyroidism Adre- nal insufficiency |
基金项目: |
|
摘要点击次数: 664 |
全文下载次数: 352 |
中文摘要: |
目的探讨儿童自身免疫性多内分泌腺病综合征 Ⅰ型( APS-Ⅰ)临床特征及 AIRE基因变异。方法回顾分析河南省儿童医院 2019年 5—10月收治的 2例 APS-Ⅰ病儿临床资料,并复习相关文献,对已报道中国儿童 APS-Ⅰ临床表型及基因型进行总结。结果 2例男性 APS-Ⅰ病儿,病例 1,12岁, 3岁慢性念珠菌感染, 12岁重度贫血;病例 2,15岁, 7岁甲状旁腺功能减退, 8岁慢性念珠菌感染, 15岁肾上腺皮质功能减退症和重度贫血。高通量测序提示 AIRE基因变异,病例 1为 c.44G>A(p.R15H)和 c.1036C>T(p.Q346*)杂合突变,病例 2为 c.38T>C(p.L13P)和 c.1400+2T>C杂合突变,其中 c.1036C>T(p.Q346*)和 c.1400+2T>C为 HGMD及 ClinVar数据库未报道过的变异位点,经美国人类遗传学和基因组学医学学会( ACMG)指南评估分别为疑似致病及致病变异。 2例病儿给予药物治疗后临床症状缓解。分别检索 PubMed、万方和 CNKI数据库,共检索到 22例确诊为 APS-Ⅰ中国病儿,包括本研究 2例,共 24例,其中 15例基因诊断,有 14种基因变异,无热点变异, 9例临床诊断。结论新的变异位点扩大了 AIRE基因变异谱, APS-Ⅰ临床表现多样,且出现时间跨度大,相关抗体及 AIRE基因检测有助于疾病早期诊断,多学科诊疗提供个体化的治疗策略。 |
英文摘要: |
Objective To investigate the clinical characteristics and AIRE gene variation of autoimmune polyendocrinopathy syn- drome type Ⅰ (APS-Ⅰ) in children.Methods The clinical data of 2 children with APS-Ⅰ admitted to He'nan Children's Hospitalfrom May 2019 to October 2019 were reviewed and analyzed, and the related literature was reviewed to summarize the clinical pheno-types and genotypes of APS-Ⅰ reported in Chinese children. Results Two male APS-Ⅰ cases were identified: case 1, 12 years old,chronic candida infection at 3 years old, severe anemia at 12 years old; case 2, 15 years old, hypoparathyroidism at 7 years old, chroniccandida infection at 8 years old, and adrenal insufficiency and severe anemia at 15 years old. High-throughput sequencing indicated AIRE gene variation in both cases: c.44G>A(p.R15H)and c.1036C>T(p.Q346*)heterozygous mutations in case 1, c.38T>C(p.L13P)andc.1400+2T>C in case 2. Among them, c.1036C > T (p.Q346*) and c.1400+2T > C were mutation sites that had not been reported inHGMD and ClinVar databases, which were respectively suspected likely pathogenic and pathogenic, according to American College ofMedical Genetics and Genomics (ACMG) guidelines. The clinical symptoms of 2 children were relieved after drug treatment. By search-ing PubMed, Wanfang, and CNKI databases separately, a total of 22 children diagnosed with APS-I in China were retrieved, including2 cases in this study, for a total of 24 cases. Among them, 15 cases were diagnosed with gene mutations, 14 with no hotspot mutations,and 9 cases were clinically diagnosed. Conclusion The new mutation sites expand the spectrum of AIRE gene variation. The clinical manifestations of APS-Ⅰ are diverse and the occurrence time span is large. Detection of related antibodies and AIRE gene is helpful for early diagnosis of the disease, and multi-disciplinary treatment provides individualized treatment strategies. |
查看全文
查看/发表评论 下载PDF阅读器 |
关闭 |
|
|
|